X hits on this document

416 views

0 shares

0 downloads

0 comments

7 / 170

6

CENTER FOR DRUG EVALUATON AND RESEARCH TEMPORARY VOTING MEMBERS

Lynn L. Levitsky, M.D. Chief, Pediatric Endocrine Unit Massachusetts General Hospital Boston, Massachusetts

Rebecca W. Killion Patient Representative Bowie, Maryland

John R. Teerlink, M.D. Associate Professor of Medicine, UCSF Director, Heart Failure Clinic, SFVAMC Director, Clinical Echocardiography, SFVAMC San Francisco VA Medical Center San Francisco, California

Kathleen L. Wyne, M.D., Ph.D. Director of Clinical Research, Diabetes Research Center The Methodist Hospital Research Institute Assistant Professor Department of Medicine Weill Cornell Medical College The Methodist Hospital Houston, Texas

Peter J. Savage, M.D. Senior Advisor to the Director Division of Diabetes, Endocrinology and Metabolic Diseases (DDEMD), NIDDK National Institutes of Health (NIH) Bethesda, Maryland

Marvin A. Konstam, M.D. Chief Physician Executive The Cardiovascular Center Tufts Medical Center Professor of Medicine Tufts University School of Medicine

FDA PARTICIPANTES (Non-Voting)

John K. Jenkins, M.D. Director Office of New Drugs Center for Drug Evaluation and Research (CDER) Food and Drug Administration (FDA)

Curtis Rosebraugh, M.D., M.P.H. Director Office of Drug Evaluation II CDER, FDA

Mary H. Parks, M.D. Director Division of Metabolism and Endocrinology Products CDER, FDA

Hylton Joffe, M.D. M.M.Sc Diabetes Clinical Team Leader Division of Metabolism and Endocrinology Products CDER, FDA

Naomi Lowry, M.D. Clinical Reviewer Division of Metabolism and Endocrinology Products CDER, FDA

Scribes, LLC Toll Free 1-800-675-8846 www.scribesllc.com

Document info
Document views416
Page views416
Page last viewedSat Dec 03 02:51:35 UTC 2016
Pages170
Paragraphs7975
Words54271

Comments